Health Myths Debunked; Astronaut’s Medical Crisis; GLP-1 for Psoriatic Arthritis
(MedPage Today) — Note that some links may require registration or subscription. Doctors debunked five women’s health myths on mammograms, menopause, exercise, and more. (NPR) The FDA rejected tasimelteon (Hetlioz) as a treatment for jet lag…
Food Exec Brief: Food Fraud’s $77B Crisis, 2026’s Regulatory Reckoning, and AI’s Value Revolution
Welcome to this week’s Food Exec Brief, your strategic intelligence roundup covering AI’s evolution from efficiency tool to value creator, the explosive growth of food fraud threatening global supply chains, and the regulatory tsunami reshaping everything from dietary guidelines to ultra-processed food definitions as we navigate 2026’s transformational landscape. Key takeaways: Food fraud surges to […]
Is Giving ChatGPT Health Your Medical Records a Good Idea?
Your AI doctor’s office is expanding. On Jan. 7, OpenAI announced that over the coming weeks, it will roll out ChatGPT Health, a dedicated tab for health that allows users to upload their medical records and connect apps like Apple Health, the personalized health testing platform Function, and MyFitnessPal. According to the company, more than […]
Nightline Full Broadcast – Thursday, January 8, 2026
01:34 – GLP-1 drugs may be helpful for addiction recovery 11:23 – Lucy Liu on her latest role 18:28 – The return of Star Search — Subscribe to ABC News on YouTube: https://abcnews.visitlink.me/59aJ1G ABC News Digital is your daily source of breaking national and world news, exclusive interviews and 24/7 live streaming coverage. Download the […]
Drug approvals to watch in 2026
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for hospital formularies, prescribing protocols and patient access. A report published Jan. 8 by GoodRx, “FDA Approval Watch: New Drugs, Vaccines, and Therapies Pending Approval in 2026” outlines several […]
VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug
Viking Therapeutics VKTX announced that it has completed enrolling patients in its exploratory maintenance dosing study of VK2735, the company’s dual agonist of the GLP-1 and GIP receptors. VKTX is developing the candidate in both oral and subcutaneous (SC) formulations for the potential treatment of various metabolic disorders, such as obesity. Viking Therapeutics’ phase I maintenance […]
Here’s Why Biotech ETFs Are Rallying Hard
Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB rallied 36.7% in six months ending Jan. 7, 2026, outperforming SPDR S&P 500 ETF Trust SPY (up 11.2%). Year to date, IBB has risen 4.2% compared […]
Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests
(MedPage Today) — Bariatric surgery and GLP-1 receptor agonists both reduced fat mass over 2 years of treatment, but surgery was associated with a more favorable body composition, a cohort study indicated. By month 24, the covariate-adjusted…
Weight loss drugs make it harder to get the nutrients you need – here’s what to do about it
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body already produces called glucagon-like peptide-1 (GLP-1), which helps regulate appetite and feelings of fullness. By slowing how quickly food leaves the stomach and acting on appetite centres in the brain, the drugs help people feel full […]
GLP-1 Drugs May Protect Against Vertebral Fractures
Glucagon-like peptide-1 (GLP-1) receptor agonists were associated with a lower vertebral fracture risk in patients with type 2 diabetes, according to a study published in JAMA Surgery.